Differences in the prevalence and severity of side effects based on type of analgesic prescription in patients with chronic cancer pain

被引:36
作者
Villars, Patrice
Dodd, Marylin
West, Claudia
Koetters, Theresa
Paul, Steven M.
Schumacher, Karen
Tripathy, Debu
Koo, Peter
Miaskowski, Christine
机构
[1] Univ Calif San Francisco, Sch Nursing, Dept Physiol Nursing, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA
[3] Univ Nebraska, Sch Nursing, Omaha, NE 68182 USA
[4] Univ Texas, SW Med Ctr, Sch Med, Dallas, TX USA
关键词
D O I
10.1016/j.jpainsymman.2006.07.011
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
An understanding of the relationship between the type of analgesic prescription rind the prevalence and severity of side effects is crucial in making appropriate treatment decisions. The purposes of this study were to determine if there were differences in the prevalence of side effects among four different types of analgesic prescriptions (i.e., no opioid, only an as needed (PRN) opioid, only an around-the-clock (ATC) opioid, or an ATC.+ PRN opioid); to determine if there were differences in the severity of side effects among the four prescription groups; and to determine the relationships between the total dose of opioid analgesic medication prescribed and taken and the severity of side effects. As part of a larger study, 174 cancer patients with bone metastasis reported their analgesic use and the prevalence and severity of 11 side effects. Significant differences (P < 0.05) were found in prevalence rates for seven of the side effects among the four prescription groups. The highest prevalence rates were found in the only ATC and ATC + PRN groups. Significant differences were found in the severity scores for five of the side effects, with the highest, severity scores reported by patients in the only ATC and ATC+ PRN groups. Significant positive correlations were found between the severity of six of the side effects and the total dose of opioid prescribed and taken. Risk factors for analgesic-induced side effects are ATC and ATC + PRN prescription types and higher doses of opioid analgesics.
引用
收藏
页码:67 / 77
页数:11
相关论文
共 28 条
[1]   A COMPARATIVE-STUDY OF CONTROLLED-RELEASE MORPHINE (CRM) SUSPENSION AND CRM TABLETS IN CHRONIC CANCER PAIN [J].
BOUREAU, F ;
SAUDUBRAY, F ;
DARNOUX, C ;
VEDRENNE, J ;
ESTEVE, M ;
ROQUEFEUIL, B ;
SIOU, DKA ;
BRUNET, R ;
RANCHERE, JY ;
ROUSSEL, P ;
RICHARD, A ;
LAUGNER, B ;
MULLER, A ;
DONNADIEU, S .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (07) :393-399
[2]   Side effects of opioids during short-term administration: Effect of age, gender, and race [J].
Cepeda, MS ;
Farrar, JT ;
Baumgarten, M ;
Boston, R ;
Carr, DB ;
Strom, BL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (02) :102-112
[3]   Ethnicity influences morphine pharmacokinetics and pharmacodynamics [J].
Cepeda, MS ;
Farrar, JT ;
Roa, JH ;
Boston, R ;
Meng, QC ;
Ruiz, F ;
Carr, DB ;
Strom, BL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (04) :351-361
[4]   Strategies to manage the adverse effects of oral morphine: An evidence-based report [J].
Cherny, N ;
Ripamonti, C ;
Pereira, J ;
Davis, C ;
Fallon, M ;
McQuay, H ;
Mercadante, S ;
Pasternak, G ;
Ventafridda, V .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (09) :2542-2554
[5]   Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain [J].
Clark, AJ ;
Ahmedzai, SH ;
Allan, LG ;
Camacho, F ;
Horbay, GLA ;
Richarz, U ;
Simpson, K .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (09) :1419-1428
[6]   DEVELOPMENT OF THE WISCONSIN BRIEF PAIN QUESTIONNAIRE TO ASSESS PAIN IN CANCER AND OTHER DISEASES [J].
DAUT, RL ;
CLEELAND, CS ;
FLANERY, RC .
PAIN, 1983, 17 (02) :197-210
[7]   Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin - Systematic review and meta-analysis of randomized controlled trials [J].
Eisenberg, E ;
McNicol, ED ;
Carr, DB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (24) :3043-3052
[8]   Morphine responses and experimental pain: Sex differences in side effects and cardiovascular responses but not analgesia [J].
Fillingim, RB ;
Ness, TJ ;
Glover, TL ;
Campbell, CM ;
Hastie, BA ;
Price, DD ;
Staud, R .
JOURNAL OF PAIN, 2005, 6 (02) :116-124
[9]   Opioids in chronic non-cancer pain: systematic review of efficacy and safety [J].
Kalso, E ;
Edwards, JE ;
Moore, RA ;
McQuay, HJ .
PAIN, 2004, 112 (03) :372-380
[10]  
KARNOFSKY D, 1977, FACTORS INFLUENCE TH